Table 2 Summarized results of bi-directional Mendelian randomization study on vitamin D and obstructive sleep apnea
MR Approaches | Vitamin D-OSA | OSA-vitamin D | OSA-vitamin D* | |||
|---|---|---|---|---|---|---|
OR (95%CI) | P | β (95% CI) | P | β (95% CI) | P | |
MR-Egger | 0.91(0.74, 1.11) | 0.35 | -0.04(-0.21, 0.12) | 0.63 | -0.05(-0.17, 0.06) | 0.41 |
Weighted median | 0.92(0.76, 1.13) | 0.45 | -0.02(-0.05, 0.005) | 0.10 | -0.03(-0.06, 0.001) | 0.06 |
IVW | 0.99(0.88, 1.12) | 0.85 | -0.02(-0.05, 0.01) | 0.22 | -0.03(-0.06, -0.01) | 0.01 |
Maximum likelihood | 0.99(0.88, 1,11) | 0.84 | -0.02(-0.04, 0.003) | 0.09 | -0.03(-0.06, -0.007) | 0.01 |